OPKO Health Inc OPK:NASDAQ

Last Price$3.44NASDAQ Previous Close - Last Trade as of 3:59PM ET 7/30/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.44 (40)
Ask (Size)$3.48 (1)
Day Low / HighN/A - N/A
Volume11.4 M
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 07/30/2021

 

OPKO Health Inc ( NASDAQ )

Price: $3.44
Change: -0.29 (7.77%)
Volume: 11.4 M
3:59PM ET 7/30/2021
 
 

Protagonist Therapeutics Inc ( NASDAQ )

Price: $49.43
Change: +2.31 (4.90%)
Volume: 517.0 K
3:59PM ET 7/30/2021
 
 

Rocket Pharmaceuticals Inc ( NASDAQ )

Price: $35.82
Change: -2.22 (5.84%)
Volume: 551.2 K
4:00PM ET 7/30/2021
 
 

Myriad Genetics Inc ( NASDAQ )

Price: $31.63
Change: +0.38 (1.22%)
Volume: 428.3 K
3:59PM ET 7/30/2021
 
 

Sorrento Therapeutics Inc ( NASDAQ )

Price: $8.21
Change: -0.18 (2.15%)
Volume: 2.7 M
4:00PM ET 7/30/2021
 

Read more news Recent News

Sector Update: Health Care Stocks Scratching Out Small Advance Just Ahead of Friday Close
3:45PM ET 7/30/2021 MT Newswires

Health care stocks were positioned to finish with small gains this afternoon, with the NYSE Health Care Index rising 0.2% while the SPDR Health Care Select...

Sector Update: Health Care
3:33PM ET 7/30/2021 MT Newswires

Health care stocks were positioned to finish with small gains this afternoon, with the NYSE Health Care Index rising 0.2% while the SPDR Health Care Select...

--Barrington Adjusts Price Target on Opko Health to $6 From $8 on Lab Unit Revenue Decline, Maintains Outperform Rating
12:30PM ET 7/30/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (OPK) OPKO HEALTH Posts Q2 Revenue $442.4M, vs. Street Est of $456.4M
4:05PM ET 7/29/2021 MT Newswires

...

Company Profile

Business DescriptionOPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Phone+1.305.575.4100
Number of Employees5,690
Recent SEC Filing06/25/20214
Chairman & Chief Executive OfficerPhillip Frost
Director & Senior Vice PresidentJon Roger Cohen
CFO, Treasurer, Chief Accounting Officer & SVPAdam E. Logal
Vice Chairman & Chief Technical OfficerJane H. Hsaio

Company Highlights

Price Open$3.36
Previous Close$3.73
52 Week Range$2.84 - 6.27
Market Capitalization$2.3 B
Shares Outstanding670.2 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/04/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings18.11
Earnings per Share$0.19
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin6.83%
Return on Equity7.34%

Analyst Ratings as of 07/02/2021

Buy
5
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset